1. Home
  2. FIBK vs RLAY Comparison

FIBK vs RLAY Comparison

Compare FIBK & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Interstate BancSystem Inc. (DE)

FIBK

First Interstate BancSystem Inc. (DE)

SELL

Current Price

$35.56

Market Cap

3.9B

Sector

Finance

ML Signal

SELL

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

BUY

Current Price

$18.41

Market Cap

4.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FIBK
RLAY
Founded
1879
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
FIBK
RLAY
Price
$35.56
$18.41
Analyst Decision
Hold
Strong Buy
Analyst Count
9
13
Target Price
★ $37.00
$27.58
AVG Volume (30 Days)
1.1M
★ 3.1M
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 5.28%
N/A
EPS Growth
★ 34.25
31.78
EPS
★ 1.47
N/A
Revenue
N/A
★ $15,355,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.16
$60.73
P/E Ratio
$24.18
★ N/A
Revenue Growth
N/A
★ 53.44
52 Week Low
$29.10
$5.84
52 Week High
$40.60
$21.27

Technical Indicators

Market Signals
Indicator
FIBK
RLAY
Relative Strength Index (RSI) 36.08 47.94
Support Level $34.07 $17.83
Resistance Level $36.46 $20.54
Average True Range (ATR) 0.68 0.97
MACD -0.10 0.06
Stochastic Oscillator 24.29 51.33

Price Performance

Historical Comparison
FIBK
RLAY

About FIBK First Interstate BancSystem Inc. (DE)

First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: